MARIE KAUFMANN: Open Payments
NPI 1447805510 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,142 in 93 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,369 · 2025 $2,142
Food & beverage: $2,142
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $311 |
| Novo Nordisk Inc | 12 | $267 |
| ABBVIE INC. | 11 | $212 |
| AstraZeneca Pharmaceuticals LP | 9 | $212 |
| Gilead Sciences, Inc. | 8 | $205 |
| ViiV Healthcare Company | 5 | $129 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $110 |
| Amgen Inc. | 4 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
Products named: NURTEC ODT, APRETUDE, CAPLYTA, PREVNAR 20, AIRSUPRA, Wegovy, Ozempic, FARXIGA.
Industry payments across VA — which companies pay providers there.
